George Norbert Cox
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$4.1MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $4.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 30, 2024 | NIH | SBIR Phase II Novel drug combinations for improving survival from acute radiation syndrome when administered 48 hours post- irradiation | $717K | BOLDER BIOTECHNOLOGY INC |
| Jan 23, 2024 | NIH | SBIR Phase I Improving survival from Burkholderia pseudomallei and other pathogenic intracellular bacteria | $296K | BOLDER BIOTECHNOLOGY INC |
| May 23, 2023 | NIH | SBIR Phase II Novel drug combinations for improving survival from acute radiation syndrome when administered 48 hours post- irradiation | $1.0M | BOLDER BIOTECHNOLOGY INC |
| Jul 2, 2021 | NIH | SBIR Phase I Stimulating innate immunity to protect against Ebola virus infection | $300K | BOLDER BIOTECHNOLOGY INC |
| Jun 10, 2020 | NIH | SBIR Phase I Novel drugs combinations for improving survival from Acute Radiation Syndrome when administered 48h postirradiation | $294K | BOLDER BIOTECHNOLOGY INC |
| Jul 11, 2019 | NIH | SBIR Phase I Novel drugs combinations for improving survival from Acute Radiation Syndrome when administered 48h postirradiation | $300K | BOLDER BIOTECHNOLOGY INC |
| Feb 24, 2015 | NIH | SBIR Phase II Long-Acting G-CSF Analog for Treating ARS | $1.2M | BOLDER BIOTECHNOLOGY INC |
Peer ranks
Federal funding#375
Awards as PI#250
Patents#273
Companies
- BOLDER BIOTECHNOLOGY INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.